Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2015, Article ID 704789, 8 pages
http://dx.doi.org/10.1155/2015/704789
Research Article

Autophagy in RAW264.7 Cells Treated with Surface-Functionalized Graphene Oxides

1Department of Internal Medicine, Chung-Ang University College of Medicine, 221 Heukseok-dong, Dongjak-gu, Seoul 156-756, Republic of Korea
2School of Chemical Engineering and Materials Science, Chung-Ang University, 221 Heukseok-dong, Dongjak-gu, Seoul 156-756, Republic of Korea

Received 19 May 2015; Accepted 21 July 2015

Academic Editor: Jin W. Seo

Copyright © 2015 Chang Seok Park et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

This study investigated cytotoxicity, particularly autophagy, in RAW264.7 cells exposed to graphene oxide (GO) and its derivatives (dodecylamine-GO (DA-GO), reduced GO (rGO), and sodium dodecyl sulfate-rGO (SDS-rGO)). Appearance of amine stretching bands, out-of-plane C-H stretching vibrations, and S=O stretching bands in infrared spectra indicated the formation of DA-GO, rGO, and SDS-rGO, respectively. Light microscopy and microculture tetrazolium assay showed that all the GO types exerted cytotoxic effects on RAW264.7 cells in a concentration-dependent manner. Higher concentrations of the GO types downregulated the expression of PU.1, a unique transcription factor in monocytes and macrophages, and decreased the conversion of LC3A/B-I to LC3A/B-II, suggesting that PU.1 was associated with autophagy in RAW264.7 cells. These results suggested that surface-functionalized GOs exerted cytotoxic effects in a concentration-dependent manner by changing the expression of critical genes and inducing autophagy in macrophages.

1. Introduction

Nanomaterials have diverse applications because of their extraordinary physicochemical characteristics. In the last decade, several novel nanomaterials have been developed that have found applications in tissue engineering and regenerative medicine. Nanomaterials affect the immune system, especially macrophages and lymphocytes, thus significantly affecting human health [1]. Graphene, which is characterized by a two-dimensional honeycomb lattice carbon structure, is a potential nanomaterial [2]. Different graphene subtypes, for example, graphene made by chemical vapor deposition, graphene nanoribbons, graphene oxide (GO), and reduced GO (rGO), can be obtained by employing different fabrication methods. Uniformly structured graphene is used as an intracellular carrier in immune cells [3]. Its favorable biological properties such as interaction with RNA and DNA, cellular adhesion, cellular uptake, antibacterial activity, and good biodegradability have increased its application in the biological field. This in turn will increase the industrial production of graphene. As a result, graphene dust may inevitably spread into the environment and may exert harmful effects on human health. Therefore, it is important to analyze the nanosafety and nanotoxicity of graphene materials.

Unique properties of graphene are important under in vivo or intracellular conditions as well as under ex vivo or extracellular conditions. GO and rGO effectively inhibit the growth of bacteria, with minimal cytotoxic effects [4]. RAW264.7 mouse macrophage cell line has long been used as an in vitro model for studying the response of inflammatory molecules to various synthetic stimuli. Macrophages are the first immune response cells that represent the innate immune system. Macrophage response is critical for survival at cell, tissue, organ, and system levels. Therefore, dose- and size-related effects of GO or rGO on the morphology, viability, and mortality of RAW264.7 cells should be considered while developing biomedical applications of GO. Most previous studies have used rGO or GO without any surface treatments. However, the physicochemical properties of GO depend on its surface [5]. The most critical issue associated with the use of rGO or GO in biomedical applications is to establish versatile functionalization methods for producing GOs that are surface functionalized with biomolecules or biomaterials, with minimal detrimental effects on the bioactivity of these compounds. Therefore, the effect of surface-functionalized GOs on the viability of RAW264.7 cells should be analyzed to determine their nanosafety. Furthermore, surface-functionalized GO-induced intracellular molecular and genetic mechanisms in RAW264.7 cells must be elucidated for determining health care and environmental controls.

Cell death occurs in the form of necrosis, apoptosis, and other forms of programmed or nonprogrammed cell death, including autophagy, which has been acknowledged recently. Autophagy is defined as nanomaterial-associated cellular injury [6]. Autophagy involves degradation of intracellular components in response to stress, and it is negatively controlled by mammalian target of rapamycin complex 1 (mTORC1). Inhibition of mTORC1 kinase activity promotes the formation of an autophagosome containing a complex composed of Beclin 1 and other factors. Formation of the autophagosome also involves the conversion of microtubule-associated protein light chain 3 (LC3A/B-I) to its lipidated form LC3A/B-II. Thus, conversion of LC3A/B-I to LC3A/B-II is a common indicator of autophagy. A study on mechanisms underlying the death of RAW264.7 cells is essential to elucidate the effects of surface-functionalized GOs on the viability of these cells. Therefore, the present study investigated the differential cellular effects of surface-functionalized GOs on the viability of and gene expression in monocytes and macrophages.

GO was produced using a modified Hummers method, and rGO was produced using hydrazine hydrate [7]. Dodecylamine (DA) and sodium dodecyl sulfate (SDS) were used to functionalize GO or rGO. Fourier transform infrared spectroscopy (FTIR) was used to determine the results of surface functionalization. Optical microscopy was used to investigate cell viability. The measurements obtained were used to elucidate the effects of GO, DA-GO, rGO, and SDS-rGO on the viability of RAW264.7 cells and the mechanisms underlying their death.

2. Materials and Methods

2.1. Synthesis of GO

GO was prepared using a modified Hummers method. Briefly, 2 g graphite powder (universal grade, 200 mesh, 99.9995%; Alfa Aesar) was stirred with 2 g NaNO3 and 100 mL concentrated H2SO4 for 1 day in an ice water bath. After stirring, 12 g KMnO4 was gradually added to the solution. After thoroughly mixing the solution, the ice bath was removed and the solution was stirred at 35°C until a highly viscous liquid was obtained. Next, 200 mL pure water and H2O2 were added sequentially to the viscous liquid, and the mixture was centrifuged at 8000 rpm and washed with HCl and water. The centrifugation and washing steps were repeated at least five times. Finally, the GO obtained was dried at 50°C for 24 h in a vacuum oven.

2.2. Synthesis of DA-GO

GO was dispersed in 200 mL deionized water to obtain a concentration of 2 mg/mL. The dispersed GO was ultrasonicated for 30 min by using WUC-A03H bath-type sonicator (Daihan Scientific, Korea). The GO dispersion was then centrifuged for 15 min at 3000 rpm to remove unexfoliated GO. Next, 100 mL of the brown-colored dispersion was transferred to a 250 mL beaker. DA (0.1853 g) dissolved in 100 mL ethanol was added to the GO dispersion, and the solution was stirred at room temperature for 2 h. Nucleophilic substitution occurred between the amino moiety of DA and the epoxy moiety of GO. This DA-functionalized GO dispersion was washed with ethanol to remove excess DA adsorbed on the surface of the modified GO. The reaction product was washed with deionized water to remove excess ethanol. The dark brown powder was dried under vacuum at 60°C for 24 h to obtain DA-GO.

2.3. Synthesis of rGO

rGO was synthesized from GO by using hydrazine hydrate. First, 0.1 g GO was dispersed in 100 mL deionized water by ultrasonication. Next, 1 mL hydrazine hydrate (N2H4 [50%–60%], reagent grade; Sigma-Aldrich) was added to the GO dispersion. After stirring for 10 min, the solution was transferred to an oil bath fitted with a water-cooled condenser, and it was heated at 90°C for 24 h. The reaction product was washed with deionized water to remove excess hydrazine hydrate. The final product was then dried in a vacuum oven at 60°C.

2.4. Synthesis of SDS-rGO

For SDS modification, rGO was dispersed in 200 mL deionized water to achieve a concentration of 2 mg/mL by performing ultrasonication for 30 min in VCX-750 probe-type sonicator (Sonics & Materials, Inc., USA). Next, 14.419 g SDS (ACS regent, ≥99.0%; Sigma-Aldrich) was added to the rGO dispersion, and the solution was stirred at room temperature for 2 h. The SDS-modified rGO (SDS-rGO) dispersion was then washed with deionized water to remove excess SDS. The black powder obtained was dried under vacuum at 60°C for 24 h.

2.5. Materials

Dulbecco’s modified Eagle’s medium (DMEM; Gibco), fetal bovine serum (FBS; Gibco), penicillin/streptomycin (Gibco), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), NaCl, Tween-20, Trizma base, glycine, and HCl were purchased from Sigma-Aldrich. PRO-PREP Protein Extraction Kit and SMART BCA Protein Assay Kit were purchased from Intron. Antibodies against glyceraldehyde-3-phosphate dehydrogenase (GAPDH), pan-actin (p-Act), LC3A/B-I, LC3A/B-II, and PU.1 were purchased from Cell Signaling.

2.6. Cell Culture and Treatment with the GO Types

Murine RAW264.7 macrophages were purchased from ATCC and cultured in DMEM supplemented with 10% FBS, 100 μg/mL streptomycin, and 100 U/mL penicillin at 37°C in 5% CO2 atmosphere. Four GO types, that is, GO, DA-GO, rGO, and SDS-rGO, were used in the study. For treatment with each GO type, the cells were seeded in proper culture plates (24-well plates, ~100φ, and 100 mm diameter) at an appropriate seeding density and cultured overnight with indicated concentrations of each GO type for 24 or 48 h.

2.7. Light Microscopy

Cell morphology was examined under a phase-contrast microscope (Olympus IX71) at 100x magnification. RAW264.7 cells were plated in 12-well plates (cell density, 2.5 × 105 cells per well) and were incubated for 24 h for stabilization. The cells were then treated with GO, DA-GO, rGO, and SDS-rGO at indicated concentrations (5, 25, and 50 μg/mL for DA-GO and 5, 50, and 200 μg/mL for GO, rGO, and SDS-rGO, resp.) for 24 or 48 h. RAW264.7 cells cultured in a complete medium without any GO type were used as controls. All images were recorded and digitalized using Olympus DP70 and its software program.

2.8. Cytotoxicity Assay

Cytotoxicity of each GO type was evaluated by performing MTT assay. Briefly, 5 mg/mL MTT solution was prepared in phosphate buffered saline (PBS; Gibco). The solution was sterilized using a syringe filter (0.2 μm pore size, GVS). RAW264.7 cells were plated in 24-well plates (cell density, 1.5 × 105 cells per well) and were incubated for 24 h for stabilization. The cells were then treated separately with GO, DA-GO, rGO, and SDS-rGO at concentrations ranging from 800 to 0.8 μg/mL, which were obtained by diluting the GO types with the culture medium. RAW264.7 cells cultured in a medium without the GO types were used as controls. Culture medium without the RAW264.7 cells or GO types was used as blank. After 24 and 48 h of incubation, the cells were rinsed twice with cold sterile PBS. Next, 10% MTT solution in the complete medium was added to each well, and the cells were incubated for additional 4 h at 37°C. Next, 100 μL 10% SDS solution was added to each well, and the cells were incubated for more than 4 h at 37°C to dissolve formazan precipitates in viable cells. Liquefied samples were agitated for 30 s to mix cells with GO thoroughly. Next, the samples were centrifuged at 14000 rpm for 30 min to precipitate the GO derivatives. Optical density was measured at 540 nm by using a microplate reader (Spectramax 340PC384; Molecular Devices), with 670 nm as the reference wavelength. The experiment was repeated thrice.

2.9. Protein Extraction and Western Blot Analysis

Each GO type was categorized into 3 groups based on its concentration (low, medium, and high concentrations). The concentrations were 5, 25, and 50 μg/mL for DA-GO and 5, 50, and 200 μg/mL for the other GO types. Total proteins were extracted by rinsing the treated cells twice with ice-cold PBS and subsequently lysing the cells in the PRO-PREP solution by using cell scrappers. The extracted components were incubated at −20°C for 20 min and then centrifuged at 15000 rpm and 4°C for 30 min. Clear supernatants containing total proteins were collected, and protein concentrations were determined using the SMART BCA Protein Assay Kit. Equal amounts of proteins were separated by performing sodium dodecyl sulfate-polyacrylamide gel electrophoresis and were transferred onto polyvinylidene fluoride membranes. The membranes were blocked with 5% nonfat milk and were incubated overnight with primary antibodies at 4°C with gentle agitation. The membranes were then incubated with appropriate secondary antibodies, and protein bands were detected using Dogen Pico or Femto Chemiluminescence Kit. Densities of protein bands were quantified using Image Lab imaging processing program. Because the extent of the conversion of LC3A/B-I to LC3A/B-II is correlated with the level of autophagy, levels of LC3A/B-I and LC3A/B-II were detected by performing western blot analysis. Conversion of LC3A/B was determined using the following formula: band density of LC3A/B-II/(band density of LC3A/B-I + band density of LC3A/B-II). Expression of p-Act, GAPDH (internal control), and PU.1 (transcription factor that serves an indicator of RAW264.7 cells) was also examined.

3. Results and Discussion

Figure 1 shows the FTIR spectra of (a) GO, (b) DA-GO, (c) rGO, and (d) SDS-rGO. Expected structures of each GO type are shown in the inset of Figure 1. A broad peak at 3437 cm−1 corresponding to O-H stretching was observed for all the samples, suggesting that rGO and SDS-rGO contained some oxygen bonds even though their oxygen content decreased after reduction. Another peak at 1636 cm−1 was also observed for all the samples, indicating the presence of graphitic sp2 bonds. Peaks around 1700–1733 cm−1 and at 1272 cm−1 were observed for GO, indicating the presence of carboxyl and epoxy groups, respectively. However, these peaks were not observed for other samples, suggesting that the carboxyl and/or epoxy groups reacted with DA in DA-GO and were reduced in rGO and SDS-rGO. The remaining peaks for GO were observed at 1380 (CH3 bending) and 1056 cm−1, which is typical for primary alcohols [8]. New peaks at 2955, 2922, and 2852 cm−1 for DA-GO corresponded to C-H stretching vibrations of CH3, CH2, and, CH groups, respectively. Peaks at 1644, 1457, 1265, and 1012 cm−1 for DA-GO corresponded to carbonyl stretching vibrations of an amide-carbonyl bond, an amine group, an amine stretching band, and a primary alcohol in phenolic compounds, respectively [9, 10]. Presence of these peaks confirmed that GO was successfully modified with DA. Peaks at 998 and 990 cm−1 for rGO and SDS-rGO, respectively, corresponded to out-of-plane C-H stretching vibrations and suggested sufficient reduction of GO. A new peak at 1168 cm−1 for SDS-rGO corresponded to S=O stretching and indicated that small amounts of SDS existed on the surface of rGO. These data indicated that all the samples were modified as intended.

Figure 1: FTIR spectra of (a) GO, (b) DA-GO, (c) rGO, and (d) SDS-rGO.

The morphology of a cell is an important indicator of its viability. Figure 2 shows microscopic images of RAW264.7 cells treated with (a) GO, (b) DA-GO, (c) rGO, and (d) SDS-rGO. The cells were exposed to 3 concentrations of GOs. Researchers or workers are likely to be exposed to low concentrations (5 μg/mL) of GOs. Intermediate (50 μg/mL) and high (200 μg/mL) concentrations of GO were examined to determine the effect of long-term exposure to GOs. Cellular morphology was conserved in almost all the cells exposed to lower concentrations of each GO type. However, cells exposed to higher concentrations of all the GO types had dysmorphic appearance. RAW264.7 cells showed loosely adherent, spindle, ovoid, or round shapes, which are characteristics of injured cells. Furthermore, cellular debris was detected in cell samples treated with all the GO types, which increased with an increase in the concentration of the GO types.

Figure 2: Microscopic images showing morphological changes in RAW264.7 cells exposed to (a) GO, (b) DA-GO, (c) rGO, and (d) SDS-rGO at the indicated concentrations for 24 h. Exposure to each GO type exerted cytotoxic effects on RAW264.7 cells.

Figure 3 shows the cytotoxicity of various GO types determined by performing the MTT assay. Cell viability decreased with an increase in the concentration of GOs, regardless of the GO type. Cell viability decreased linearly in cells treated with GO and decreased rapidly in cells treated with higher concentrations (>25 μg/mL) of rGO and SDS-rGO. Cells treated with 0.8 μg/mL DA-GO showed remarkably decreased viability that was also observed in cells treated with 12.5 μg/mL DA-GO. Cells treated with DA-GO concentrations higher than 12.5 μg/mL showed a rapid decrease in viability, suggesting that GO types with different functional groups exerted different cytotoxic effects. No difference was observed in the concentration-dependent decrease in cell viability between cells treated for 24 and 48 h.

Figure 3: Viability of RAW264.7 cells treated with (a) GO, (b) DA-GO, (c) rGO, and (d) SDS-rGO.

Figure 4 shows the results of western blot analysis of cells treated with (a) GO, (b) DA-GO, (c) rGO, and (d) SDS-rGO. Expression of p-Act decreased in a dose-dependent manner in all the samples. In contrast, expression of GAPDH was constant in all the samples. Therefore, GAPDH was used as a housekeeping gene for normalizing the semiquantitative analysis of gene expression. PU.1, NFκB, and AP-1 are representative transcription factors in cells belonging to the monocyte lineage. Surface-functionalized GOs downregulated the expression of PU.1 in a concentration-dependent manner. The ratio of conversion of LC3A/B-I to LC3A/B-II also decreased in a dose-dependent manner except for RAW264.7 cells with SDS-rGO at a concentration of 200 μg/mL for 48 h, which was similar to that observed with PU.1.

Figure 4: Expression of GAPDH, p-Act, PU.1, and autophagy marker proteins in RAW264.7 cells treated with the different concentrations of GO types for different treatment durations. (a) Representative results of western blot analysis of each protein. (b) Changes in the ratio of LC3A/B-II/(LC3A/B-I + LC3A/B-II) as a function of GO concentration and treatment duration. Level of LC3A/B-I and LC3A/B-II expression was analyzed by western blot analysis by using specific antibodies.

Based on these observations, the effects of GO and its functionalized derivatives on autophagy in monocytes/macrophages can be explained as follows. Macrophages engulf graphene materials and convert them into biodegradable intracellular nanomaterials [11, 12]. Macrophages inhibit the endocytosis of polyethylene glycol- and bovine serum albumin-functionalized graphene but stimulate the endocytosis of polyetherimide-functionalized graphene [13, 14]. These results indicate that surface-functionalized graphene exerts diverse effects from biodegradation to nanotoxicity that may injure various organs [15].

Graphene induces apoptosis, autophagy, and inflammation in macrophages through NFκB or p38 MAPK by increasing the expression of TNF-α [16, 17]. Autophagy is a type of programmed cell death, like apoptosis. Autophagy involves multiple processes such as phagocytosis or endocytosis, formation of the autophagosome, recycling of intracellular proteins, and degradation of extracellular antigens. At the cellular level, autophagy can determine cell fate, that is, survival or death. LC3 processing is a marker of autophagy because it is a major step in the formation of the autophagosome. Generally, conversion of LC3A/B-I to LC3A/B-II indicates the activation of autophagy because it involves ubiquitinase-like enzymes that cause the selective degradation of target molecules [18]. In the present study, the ratio of conversion of LC3A/B-I to LC3A/B-II decreased in a dose-dependent manner (Figure 4), suggesting that autophagy was one of the cell death processes in macrophages with the different degrees of contribution. PU.1 is one of the transcription factors in monocytes and plays pivotal roles in the expression of various genes [19, 20]. Expression of PU.1 indicates the involvement of apoptotic pathways [21, 22]. Interestingly, exposure of RAW246.7 cells to higher concentrations of GO types decreased the expression of PU.1 and conversion of LC3A/B-I to LC3A/B-II. These results suggest that PU.1 plays a regulatory role in inducing autophagy in RAW246.7 cells. Furthermore, GAPDH expression was not affected by the increase in the concentrations of GO types. To the best of our knowledge, this is the first report on constant GAPDH expression in macrophages exposed to surface-functionalized GOs. Therefore, GAPDH may be used instead of p-Act to normalize gene expression in macrophages. These results highlight the need for further studies to determine mechanisms underlying immune response or cellular toxicity, including autophagy, to establish strategies for preventing or treating respiratory and immunological toxicities in humans. Furthermore, these results indicate that appropriate preparation of GOs is necessary in manufacturing plants and industrial environments.

4. Conclusion

This study investigated the cytotoxic effects of GO, DA-GO, rGO, and SDS-rGO on RAW264.7 cells. Appearance of amine stretching bands, out-of-plane C-H stretching vibrations, and S=O stretching in FTIR spectra indicated the formation of DA-GO, rGO, and SDS-rGO, respectively. Light microscopy and MTT assay showed that all the GO types exerted cytotoxic effects in a concentration-dependent manner. Western blot analysis confirmed cytotoxicity, decreased expression of PU.1, and induction of autophagy in a concentration-dependent manner in macrophages treated with the 4 GO types. These results suggested that surface-functionalized GOs exerted cytotoxic effects in a concentration-dependent manner by changing the expression of critical genes and by inducing autophagy.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Authors’ Contribution

Chang Seok Park and Kyoung Soon Choi contributed equally to this work.

Acknowledgments

This work was supported in part by a Research Scholarship Grant of 2015 from the Chung-Ang University and by a grant from the National Research Foundation of Korea that is funded by the Korean government (MSIP; no. 2014R1A2A1A11051).

References

  1. M. Orecchioni, D. Bedognetti, F. Sgarrella, F. M. Marincola, A. Bianco, and L. G. Delogu, “Impact of carbon nanotubes and graphene on immune cells,” Journal of Translational Medicine, vol. 12, no. 1, article no. 138, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. K. C. Kwon, K. S. Choi, B. J. Kim, J.-L. Lee, and S. Y. Kim, “Work-function decrease of graphene sheet using alkali metal carbonates,” The Journal of Physical Chemistry C, vol. 116, no. 50, pp. 26586–26591, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Sun, J. Chao, J. Huang et al., “Uniform small graphene oxide as an efficient cellular nanocarrier for immunostimulatory CpG oligonucleotides,” ACS Applied Materials & Interfaces, vol. 6, no. 10, pp. 7926–7932, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Bussy, H. Ali-Boucetta, and K. Kostarelos, “Safety considerations for graphene: lessons learnt from carbon nanotubes,” Accounts of Chemical Research, vol. 46, no. 3, pp. 692–701, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Li, L. Feng, X. Shi et al., “Surface coating-dependent cytotoxicity and degradation of graphene derivatives: towards the design of non-toxic, degradable nano-graphene,” Small, vol. 10, no. 8, pp. 1544–1554, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Wan, Z.-X. Wang, Q.-Y. Lv et al., “Single-walled carbon nanotubes and graphene oxides induce autophagosome accumulation and lysosome impairment in primarily cultured murine peritoneal macrophages,” Toxicology Letters, vol. 221, no. 2, pp. 118–127, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Y. Lee, Q. V. Le, C. Kim, and S. Y. Kim, “Use of silane-functionalized graphene oxide in organic photovoltaic cells and organic light-emitting diodes,” Physical Chemistry Chemical Physics, vol. 17, no. 14, pp. 9369–9374, 2015. View at Publisher · View at Google Scholar
  8. H. Wang, Q. Hao, X. Yang, L. Lu, and X. Wang, “Effect of graphene oxide on the properties of its composite with polyaniline,” ACS Applied Materials and Interfaces, vol. 2, no. 3, pp. 821–828, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Kuila, P. Khanra, A. K. Mishra, N. H. Kim, and J. H. Lee, “Functionalized-graphene/ethylene vinyl acetate co-polymer composites for improved mechanical and thermal properties,” Polymer Testing, vol. 31, no. 2, pp. 282–289, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Wang, X. Shen, B. Wang, J. Yao, and J. Park, “Synthesis and characterisation of hydrophilic and organophilic graphene nanosheets,” Carbon, vol. 47, no. 5, pp. 1359–1364, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. H. Shin, S. G. Han, J. K. Kim et al., “5-Day repeated inhalation and 28-day post-exposure study of graphene,” Nanotoxicology, pp. 1–9, 2015. View at Publisher · View at Google Scholar
  12. M. Zhang, M. Yang, C. Bussy, S. Iijima, K. Kostarelos, and M. Yudasaka, “Biodegradation of carbon nanohorns in macrophage cells,” Nanoscale, vol. 7, no. 7, pp. 2834–2840, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Luo, D. Ni, H. Yue, W. Wei, and G. Ma, “Surface-engineered graphene navigate divergent biological outcomes toward macrophages,” ACS Applied Materials & Interfaces, vol. 7, no. 9, pp. 5239–5247, 2015. View at Publisher · View at Google Scholar
  14. J. Linares, M. C. Matesanz, M. Vila et al., “Endocytic mechanisms of graphene oxide nanosheets in osteoblasts, hepatocytes and macrophages,” ACS Applied Materials & Interfaces, vol. 6, no. 16, pp. 13697–13706, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Volarevic, V. Paunovic, Z. Markovic et al., “Large graphene quantum dots alleviate immune-mediated liver damage,” ACS Nano, vol. 8, no. 12, pp. 12098–12109, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Qin, Z.-W. Zhou, S.-T. Pan et al., “Graphene quantum dots induce apoptosis, autophagy, and inflammatory response via p38 mitogen-activated protein kinase and nuclear factor-κB mediated signaling pathways in activated THP-1 macrophages,” Toxicology, vol. 327, pp. 62–76, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. M. J. Feito, M. Vila, M. C. Matesanz et al., “In vitro evaluation of graphene oxide nanosheets on immune function,” Journal of Colloid and Interface Science, vol. 432, pp. 221–228, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Glick, S. Barth, and K. F. Macleod, “Autophagy: cellular and molecular mechanisms,” The Journal of Pathology, vol. 221, no. 1, pp. 3–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Haimovici, D. Brigger, B. E. Torbett, M. F. Fey, and M. P. Tschan, “Induction of the autophagy-associated gene MAP1S via PU.1 supports APL differentiation,” Leukemia Research, vol. 38, no. 9, pp. 1041–1047, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Brigger, T. Proikas-Cezanne, and M. P. Tschan, “WIPI-Dependent autophagy during neutrophil differentiation of NB4 acute promyelocytic leukemia cells,” Cell Death & Disease, vol. 5, no. 7, Article ID e1315, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Ueno, H. Tatetsu, H. Hata et al., “PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAIL,” Oncogene, vol. 28, no. 46, pp. 4116–4125, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Zhao, X.-F. Duan, D.-H. Wen, and G.-Q. Chen, “PU.1, a novel capase-3 substrate, partially contributes to chemotherapeutic agents-induced apoptosis in leukemic cells,” Biochemical and Biophysical Research Communications, vol. 382, no. 3, pp. 508–513, 2009. View at Publisher · View at Google Scholar · View at Scopus